{"id":25191,"date":"2025-12-09T12:40:44","date_gmt":"2025-12-09T12:40:44","guid":{"rendered":"https:\/\/itbusinesstoday.com\/?p=25191"},"modified":"2025-12-09T12:40:44","modified_gmt":"2025-12-09T12:40:44","slug":"kura-and-kyowa-report-strong-komzifti-aml-data","status":"publish","type":"post","link":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/kura-and-kyowa-report-strong-komzifti-aml-data\/","title":{"rendered":"\u30af\u30e9\u3068\u5354\u548c\u3001KOMZIFTI AML\u30c7\u30fc\u30bf\u306e\u597d\u8abf\u3092\u5831\u544a"},"content":{"rendered":"

\u30af\u30e9\u30fb\u30aa\u30f3\u30b3\u30ed\u30b8\u30fc\u3068 \u5354\u548c\u30ad\u30ea\u30f3<\/a> KOMZIFTI\u30b8\u30d5\u30c8\u30e1\u30cb\u30d6\u3068\u30d9\u30cd\u30c8\u30af\u30e9\u30c3\u30af\u30b9\u304a\u3088\u3073\u30a2\u30b6\u30b7\u30c1\u30b8\u30f3\u306e\u4f75\u7528\u7642\u6cd5\u306b\u95a2\u3059\u308b\u65b0\u305f\u306a\u30c7\u30fc\u30bf\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002NPM1\u907a\u4f1d\u5b50\u5909\u7570\u307e\u305f\u306fKMT2A\u518d\u914d\u5217\u3092\u6709\u3059\u308b\u65b0\u898f\u8a3a\u65ad\u304a\u3088\u3073\u518d\u767a\u30fb\u96e3\u6cbb\u6027AML\u306e\u4e21\u65b9\u3067\u826f\u597d\u306a\u7d50\u679c\u304c\u5f97\u3089\u308c\u307e\u3057\u305f\u3002\u3053\u306e\u7d50\u679c\u306f\u3001\u73fe\u5728\u9032\u884c\u4e2d\u306eKOMET 007\u30d5\u30a7\u30fc\u30ba1a\/1b\u8a66\u9a13\u304b\u3089\u5f97\u3089\u308c\u305f\u3082\u306e\u3067\u3001\u672c\u65e5ASH 2025\u3067\u767a\u8868\u3055\u308c\u307e\u3057\u305f\u3002.<\/p>\n

\u65b0\u305f\u306bNPM1\u5909\u7570AML\u3068\u8a3a\u65ad\u3055\u308c\u305f\u60a3\u8005\u306b\u304a\u3044\u3066\u3001\u30c8\u30ea\u30d7\u30ec\u30c3\u30c8\u306f\u5f37\u529b\u306a\u52b9\u679c\u3092\u793a\u3057\u307e\u3057\u305f\u3002\u8a55\u4fa1\u53ef\u80fd\u306a37\u4eba\u306e\u60a3\u8005\u306e\u3046\u3061\u3001CRc\u306f86\uff05\u3001\u5b8c\u5168\u594f\u52b9\u306f73\uff05\u3067\u3057\u305f\u3002\u6700\u3082\u9855\u8457\u3060\u3063\u305f\u306e\u306f\u3001CRc\u594f\u52b9\u4f8b\u306e68\u30d1\u30fc\u30bb\u30f3\u30c8\u304c\u4e2d\u592eNGS\u306b\u3088\u3063\u3066\u5206\u5b50\u7684MRD\u3092\u30af\u30ea\u30a2\u3057\u305f\u3053\u3068\u3067\u3059\u3002\u594f\u52b9\u671f\u9593\u3068\u5168\u751f\u5b58\u671f\u9593\u306e\u4e2d\u592e\u5024\u306b\u306f\u307e\u3060\u9054\u3057\u3066\u3044\u307e\u305b\u3093\u3002\u30c7\u30fc\u30bf\u30ab\u30c3\u30c8\u30aa\u30d5\u6642\u70b9\u3067\u3001\u60a3\u8005\u306e3\u5206\u306e2\u306f\u307e\u3060\u751f\u5b58\u3057\u3066\u304a\u308a\u3001\u6cbb\u7642\u4e2d\u304b\u9577\u671f\u30d5\u30a9\u30ed\u30fc\u30a2\u30c3\u30d7\u4e2d\u3067\u3057\u305f\u3002\u5b89\u5168\u6027\u306f\u30d9\u30cd\u30c8\u30af\u30e9\u30c3\u30af\u30b9\u3068\u30a2\u30b6\u30b7\u30c1\u30b8\u30f3\u306b\u901a\u5e38\u671f\u5f85\u3055\u308c\u308b\u3082\u306e\u3068\u540c\u3058\u3067\u3057\u305f\u3002\u30b8\u30d5\u30c8\u30e1\u30cb\u30d6\u306f\u6bd2\u6027\u3092\u9ad8\u3081\u308b\u3053\u3068\u306f\u3042\u308a\u307e\u305b\u3093\u3067\u3057\u305f\u3002\u9aa8\u9ac4\u6291\u5236\u306f\u4f4e\u304f\u4fdd\u305f\u308c\u3001\u9aa8\u9ac4\u6570\u306e\u56de\u5fa9\u6642\u9593\u3082\u307b\u307c\u540c\u3058\u3067\u3057\u305f\u3002\u7ba1\u7406\u53ef\u80fd\u306a\u5206\u5316\u75c7\u5019\u7fa4\u3068QTc\u5ef6\u9577\u306e\u5358\u767a\u75c7\u4f8b\u304c\u3042\u308a\u307e\u3057\u305f\u304c\u3001\u6cbb\u7642\u4e2d\u6b62\u306b\u306f\u81f3\u308a\u307e\u305b\u3093\u3067\u3057\u305f\u3002.<\/p>\n

\u518d\u767a\u307e\u305f\u306f\u96e3\u6cbb\u6027\u3067\u3082\u540c\u3058\u3088\u3046\u306a\u30d1\u30bf\u30fc\u30f3\u304c\u898b\u3089\u308c\u307e\u3057\u305f\u3002R R NPM1\u5909\u7570AML\u3067\u306f\u3001\u5168\u594f\u52b9\u7387\u306f65\u30d1\u30fc\u30bb\u30f3\u30c8\u306b\u9054\u3057\u3001CRc\u306f48\u30d1\u30fc\u30bb\u30f3\u30c8\u306b\u9054\u3057\u307e\u3057\u305f\u3002\u30d9\u30cd\u30c8\u30af\u30e9\u30c3\u30af\u30b9\u672a\u6295\u4e0e\u306e\u60a3\u8005\u3067\u306f\u3001\u5168\u594f\u52b9\u738783\u30d1\u30fc\u30bb\u30f3\u30c8\u3001CRc70\u30d1\u30fc\u30bb\u30f3\u30c8\u3068\u3055\u3089\u306b\u826f\u597d\u306a\u53cd\u5fdc\u3067\u3057\u305f\u3002\u5168\u751f\u5b58\u671f\u9593\u4e2d\u592e\u5024\u306f55\u9031\u9593\u5f31\u3067\u3057\u305f\u3002\u4f55\u4eba\u304b\u306e\u60a3\u8005\u306f\u79fb\u690d\u306b\u79fb\u884c\u3057\u3001\u4f55\u4eba\u304b\u306e\u60a3\u8005\u306f\u30b8\u30d5\u30c8\u30e1\u30cb\u30d6\u7dad\u6301\u7642\u6cd5\u3092\u7d99\u7d9a\u3057\u307e\u3057\u305f\u3002.<\/p>\n

\u3053\u3061\u3089\u3082\u304a\u8aad\u307f\u304f\u3060\u3055\u3044\uff1a \u660e\u6cbb\u88fd\u83d3\u3001\u30ea\u30ea\u30c3\u30af\u30d0\u30a4\u30aa\u306e\u30a4\u30b0\u88fd\u9020\u3092\u652f\u63f4<\/a><\/h4>\n

R R KMT2A\u518d\u914d\u5217\u578bAML\u306b\u5bfe\u3057\u3066\u306f\u3001\u3053\u306e\u30b3\u30f3\u30dc\u306f\u4f9d\u7136\u3068\u3057\u3066\u610f\u5473\u306e\u3042\u308b\u6d3b\u6027\u3092\u793a\u3057\u307e\u3057\u305f\u3002ORR\u306f41\uff05\u3001CRc\u306f28\uff05\u3067\u3057\u305f\u3002\u30d9\u30cd\u30c8\u30af\u30e9\u30af\u30b9\u672a\u6295\u4e0e\u306e\u60a3\u8005\u3067\u3082\u3001ORR70\uff05\u3001CRc60\uff05\u3068\u518d\u3073\u6d3b\u6027\u304c\u56de\u5fa9\u3057\u307e\u3057\u305f\u3002\u5168\u751f\u5b58\u671f\u9593\u4e2d\u592e\u5024\u306f21\u9031\u9593\u5f37\u3067\u3057\u305f\u3002\u3053\u306e\u3046\u30612\u4f8b\u306f\u79fb\u690d\u306b\u9032\u307f\u3001\u305d\u306e\u5f8c\u7dad\u6301\u7642\u6cd5\u3092\u53d7\u3051\u307e\u3057\u305f\u3002\u30b8\u30d5\u30c8\u30e1\u30cb\u30d6\u306b\u95a2\u9023\u3059\u308b\u65b0\u305f\u306a\u554f\u984c\u306f\u306a\u304f\u3001\u5b89\u5168\u6027\u306f\u518d\u3073\u5b89\u5b9a\u3057\u307e\u3057\u305f\u30021\u4f8b\u306e\u9451\u5225\u75c7\u5019\u7fa4\u306f\u30d7\u30ed\u30c8\u30b3\u30fc\u30eb\u6307\u793a\u306b\u3088\u308b\u6cbb\u7642\u3067\u89e3\u6c7a\u3057\u3001\u6cbb\u7642\u304c\u518d\u958b\u3055\u308c\u307e\u3057\u305f\u3002.<\/p>\n

Kura\u793e\u306eCMO\u3067\u3042\u308bMollie Leoni\u6c0f\u306f\u3001\u5b89\u5168\u6027\u3068\u53cd\u5fdc\u306e\u6df1\u3055\u304c\u4e21\u7fa4\u3067\u4e00\u8cab\u3057\u3066\u3044\u308b\u3053\u3068\u3092\u5f37\u8abf\u3057\u307e\u3057\u305f\u3002\u540c\u793e\u306f\u5f15\u304d\u7d9a\u304d\u3001\u30d5\u30ed\u30f3\u30c8\u30e9\u30a4\u30f3\u3068\u518d\u767a\u30fb\u96e3\u6cbb\u6027AML\u306e\u4e21\u65b9\u3092\u5bfe\u8c61\u3068\u3057\u305f\u91cd\u8981\u306aKOMET 017\u8a66\u9a13\u3092\u9032\u3081\u3066\u3044\u304d\u307e\u3059\u3002.<\/p>\n

\u8535<\/a> \u306f\u672c\u65e5\u5348\u5f8c12\u664230\u5206\uff08\u7c73\u56fd\u6771\u90e8\u6642\u9593\uff09\u3088\u308a\u3001\u540c\u793e\u306e\u30ea\u30fc\u30c0\u30fc\u30b7\u30c3\u30d7\u3068\u81e8\u5e8a\u5c02\u9580\u5bb6\u306b\u3088\u308b\u30d0\u30fc\u30c1\u30e3\u30eb\u6295\u8cc7\u5bb6\u30a4\u30d9\u30f3\u30c8\u3092\u958b\u50ac\u3057\u307e\u3059\u3002ASH\u3067\u306e\u8b1b\u6f14\u306e\u30b9\u30e9\u30a4\u30c9\u306f\u5f53\u793e\u30a6\u30a7\u30d6\u30b5\u30a4\u30c8\u3067\u3054\u89a7\u3044\u305f\u3060\u3051\u307e\u3059\u3002.<\/p>","protected":false},"excerpt":{"rendered":"

Kura Oncology and Kyowa Kirin rolled out fresh data on KOMZIFTI ziftomenib paired with venetoclax and azacitidine. The numbers land well for both newly diagnosed and relapsed or refractory AML with NPM1 mutations or KMT2A rearrangements. The readout comes from the ongoing KOMET 007 Phase 1a\/1b study and was presented today at ASH 2025. In newly diagnosed NPM1 mutated AML the triplet came in strong. Among 37 evaluable patients CRc hit 86 percent and complete responses landed at 73 percent. Most striking was that 68 percent of CRc responders cleared molecular MRD by central NGS. Median duration of response and overall survival have not even been reached yet. Two thirds […]<\/p>\n","protected":false},"author":7,"featured_media":25211,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"wprm-recipe-roundup-name":"","wprm-recipe-roundup-description":"","postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"footnotes":""},"categories":[208,89,211,237,182,206],"tags":[9640,3004,574,424,9639],"ppma_author":[572],"class_list":["post-25191","post","type-post","status-publish","format-standard","has-post-thumbnail","category-apac","category-health-tech","category-japan","category-news","category-pharma","category-regional","tag-komzifti","tag-kura-oncology","tag-kyowa-kirin","tag-pharma","tag-venetoclax"],"yoast_head":"\nKura, Kyowa Kirin Show Strong KOMZIFTI AML Results<\/title>\n<meta name=\"description\" content=\"Kura Oncology and Kyowa Kirin report promising KOMZIFTI AML results from the Phase 1a\/1b KOMET 007 study, benefiting patient groups.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/kura-and-kyowa-report-strong-komzifti-aml-data\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kura, Kyowa Kirin Show Strong KOMZIFTI AML Results\" \/>\n<meta property=\"og:description\" content=\"Kura Oncology and Kyowa Kirin report promising KOMZIFTI AML results from the Phase 1a\/1b KOMET 007 study, benefiting patient groups.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/kura-and-kyowa-report-strong-komzifti-aml-data\/\" \/>\n<meta property=\"og:site_name\" content=\"itbusinesstoday\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-09T12:40:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/12\/Kura-Oncology-and-Kyowa-Kirin-Report-Combination-Data-for-KOMZIFTI\u2122-Ziftomenib-with-Venetoclax-and-Azacitidine-in-Newly-Diagnosed-and-Relapsed-Refractory-AML.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"ITBT StaffWriter\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"ITBT StaffWriter\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30af\u30e9\u3068\u5354\u548c\u30ad\u30ea\u30f3\u3001KOMZIFTI AML\u3067\u597d\u6210\u7e3e\u3092\u53ce\u3081\u308b","description":"\u30af\u30e9\u30fb\u30aa\u30f3\u30b3\u30ed\u30b8\u30fc\u3068\u5354\u548c\u30ad\u30ea\u30f3\u306f\u3001\u7b2c1a\/1b\u76f8KOMET 007\u8a66\u9a13\u306b\u304a\u3051\u308bKOMZIFTI\u306e\u6025\u6027\u9aa8\u9ac4\u6027\u767d\u8840\u75c5\uff08AML\uff09\u306b\u5bfe\u3059\u308b\u6709\u671b\u306a\u7d50\u679c\u3092\u767a\u8868\u3057\u3001\u60a3\u8005\u30b0\u30eb\u30fc\u30d7\u306b\u6069\u6075\u3092\u3082\u305f\u3089\u3057\u3066\u3044\u307e\u3059\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/kura-and-kyowa-report-strong-komzifti-aml-data\/","og_locale":"ja_JP","og_type":"article","og_title":"Kura, Kyowa Kirin Show Strong KOMZIFTI AML Results","og_description":"Kura Oncology and Kyowa Kirin report promising KOMZIFTI AML results from the Phase 1a\/1b KOMET 007 study, benefiting patient groups.","og_url":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/kura-and-kyowa-report-strong-komzifti-aml-data\/","og_site_name":"itbusinesstoday","article_published_time":"2025-12-09T12:40:44+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/12\/Kura-Oncology-and-Kyowa-Kirin-Report-Combination-Data-for-KOMZIFTI\u2122-Ziftomenib-with-Venetoclax-and-Azacitidine-in-Newly-Diagnosed-and-Relapsed-Refractory-AML.webp","type":"image\/webp"}],"author":"ITBT StaffWriter","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"ITBT StaffWriter","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/kura-and-kyowa-report-strong-komzifti-aml-data\/#article","isPartOf":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/kura-and-kyowa-report-strong-komzifti-aml-data\/"},"author":{"name":"ITBT StaffWriter","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15"},"headline":"Kura and Kyowa Report Strong KOMZIFTI AML Data","datePublished":"2025-12-09T12:40:44+00:00","mainEntityOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/kura-and-kyowa-report-strong-komzifti-aml-data\/"},"wordCount":386,"publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/kura-and-kyowa-report-strong-komzifti-aml-data\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/12\/Kura-Oncology-and-Kyowa-Kirin-Report-Combination-Data-for-KOMZIFTI\u2122-Ziftomenib-with-Venetoclax-and-Azacitidine-in-Newly-Diagnosed-and-Relapsed-Refractory-AML.webp","keywords":["KOMZIFTI","Kura Oncology","Kyowa Kirin","Pharma","venetoclax"],"articleSection":["APAC","Health Tech","Japan","News","Pharma","Regional"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/kura-and-kyowa-report-strong-komzifti-aml-data\/","url":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/kura-and-kyowa-report-strong-komzifti-aml-data\/","name":"\u30af\u30e9\u3068\u5354\u548c\u30ad\u30ea\u30f3\u3001KOMZIFTI AML\u3067\u597d\u6210\u7e3e\u3092\u53ce\u3081\u308b","isPartOf":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website"},"primaryImageOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/kura-and-kyowa-report-strong-komzifti-aml-data\/#primaryimage"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/kura-and-kyowa-report-strong-komzifti-aml-data\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/12\/Kura-Oncology-and-Kyowa-Kirin-Report-Combination-Data-for-KOMZIFTI\u2122-Ziftomenib-with-Venetoclax-and-Azacitidine-in-Newly-Diagnosed-and-Relapsed-Refractory-AML.webp","datePublished":"2025-12-09T12:40:44+00:00","description":"\u30af\u30e9\u30fb\u30aa\u30f3\u30b3\u30ed\u30b8\u30fc\u3068\u5354\u548c\u30ad\u30ea\u30f3\u306f\u3001\u7b2c1a\/1b\u76f8KOMET 007\u8a66\u9a13\u306b\u304a\u3051\u308bKOMZIFTI\u306e\u6025\u6027\u9aa8\u9ac4\u6027\u767d\u8840\u75c5\uff08AML\uff09\u306b\u5bfe\u3059\u308b\u6709\u671b\u306a\u7d50\u679c\u3092\u767a\u8868\u3057\u3001\u60a3\u8005\u30b0\u30eb\u30fc\u30d7\u306b\u6069\u6075\u3092\u3082\u305f\u3089\u3057\u3066\u3044\u307e\u3059\u3002.","breadcrumb":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/kura-and-kyowa-report-strong-komzifti-aml-data\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/itbusinesstoday.com\/health-tech\/pharma\/kura-and-kyowa-report-strong-komzifti-aml-data\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/kura-and-kyowa-report-strong-komzifti-aml-data\/#primaryimage","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/12\/Kura-Oncology-and-Kyowa-Kirin-Report-Combination-Data-for-KOMZIFTI\u2122-Ziftomenib-with-Venetoclax-and-Azacitidine-in-Newly-Diagnosed-and-Relapsed-Refractory-AML.webp","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/12\/Kura-Oncology-and-Kyowa-Kirin-Report-Combination-Data-for-KOMZIFTI\u2122-Ziftomenib-with-Venetoclax-and-Azacitidine-in-Newly-Diagnosed-and-Relapsed-Refractory-AML.webp","width":1200,"height":800,"caption":"Kura Oncology"},{"@type":"BreadcrumbList","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/kura-and-kyowa-report-strong-komzifti-aml-data\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/itbusinesstoday.com\/"},{"@type":"ListItem","position":2,"name":"Kura and Kyowa Report Strong KOMZIFTI AML Data"}]},{"@type":"WebSite","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","description":"","publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","width":663,"height":275,"caption":"itbusinesstoday"},"image":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15","name":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png90b3cb23d1d9c08733d969d29ea2d30d","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","caption":"ITBT StaffWriter"},"description":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc\u306f\u3001IT Business Today\u306e\u793e\u5185\u5bc4\u7a3f\u8005\u3067\u3001\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u30cb\u30e5\u30fc\u30b9\u3068QuickBytes\u306e\u914d\u4fe1\u3092\u62c5\u5f53\u3057\u3066\u3044\u307e\u3059\u3002IT\u3001\u30cf\u30a4\u30c6\u30af\u3001\u4f01\u696d\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u6700\u65b0\u52d5\u5411\u3092\u30ab\u30d0\u30fc\u3057\u3001\u7c21\u6f54\u3067\u30a4\u30f3\u30d1\u30af\u30c8\u306e\u3042\u308b\u6700\u65b0\u60c5\u5831\u3092\u8aad\u8005\u306b\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002","sameAs":["https:\/\/itbusinesstoday.com\/"],"url":"https:\/\/itbusinesstoday.com\/ja\/author\/itbt-staffwriter\/"}]}},"authors":[{"term_id":572,"user_id":7,"is_guest":0,"slug":"itbt-staffwriter","display_name":"ITBT StaffWriter","avatar_url":{"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","url2x":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png"},"0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/25191","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/comments?post=25191"}],"version-history":[{"count":1,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/25191\/revisions"}],"predecessor-version":[{"id":25192,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/25191\/revisions\/25192"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media\/25211"}],"wp:attachment":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media?parent=25191"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/categories?post=25191"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/tags?post=25191"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/ppma_author?post=25191"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}